200,000+ products from a single source!

sales@angenechem.com

Home > Aldehydes > 6361-21-3

6361-21-3

6361-21-3 | 2-Chloro-5-nitrobenzaldehyde

CAS No: 6361-21-3 Catalog No: AG003GZF MDL No:MFCD00007293

Product Description

Catalog Number:
AG003GZF
Chemical Name:
2-Chloro-5-nitrobenzaldehyde
CAS Number:
6361-21-3
Molecular Formula:
C7H4ClNO3
Molecular Weight:
185.5646
MDL Number:
MFCD00007293
IUPAC Name:
2-chloro-5-nitrobenzaldehyde
InChI:
InChI=1S/C7H4ClNO3/c8-7-2-1-6(9(11)12)3-5(7)4-10/h1-4H
InChI Key:
VFVHWCKUHAEDMY-UHFFFAOYSA-N
SMILES:
O=Cc1cc(ccc1Cl)[N+](=O)[O-]
EC Number:
228-830-0
UNII:
PF4ILL0I3H
NSC Number:
129753

Properties

Complexity:
192  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
184.988g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
185.563g/mol
Monoisotopic Mass:
184.988g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
62.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2  

Literature

Title Journal
(E)-N'-(2-Chloro-5-nitro-benzyl-idene)-3-meth-oxy-benzohydrazide monohydrate. Acta crystallographica. Section E, Structure reports online 20110701
3-Chloro-N'-(2-chloro-5-nitro-benzyl-idene)-benzohydrazide. Acta crystallographica. Section E, Structure reports online 20110701
2-Chloro-5-nitro-benzaldehyde thio-semicarbazone. Acta crystallographica. Section E, Structure reports online 20101001
4-[6,8-Dibromo-2-(2-chloro-5-nitro-phen-yl)-1,2,3,4-tetra-hydro-quinazolin-3-yl]cyclo-hexa-nol. Acta crystallographica. Section E, Structure reports online 20100501
N'-(2-Chloro-5-nitro-benzyl-idene)isonicotinohydrazide. Acta crystallographica. Section E, Structure reports online 20090301
(E)-N'-(2-Chloro-5-nitro-benzyl-idene)-4-methoxy-benzohydrazide. Acta crystallographica. Section E, Structure reports online 20081101

© 2019 Angene International Limited. All rights Reserved.